Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006

Acta Oncologica

Volumn 49, Issue 5, 2010, Pages 655-664

  Engholm, Gerda ^a   Hakulinen, Timo ^b   Gislum, Mette ^a   Tryggvadóttir, Laufey ^c,d   Klint, Åsa ^e   Bray, Freddie ^f,g   Storm, Hans H ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b FINNISH CANCER REGISTRY   (Finland)

^c ICELANDIC CANCER SOCIETY   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^f Cancer Registry of Norway ^*  (Norway)

^g UNIVERSITY OF OSLO   (Norway)

Author keywords

Cancer registry; Excess mortality; Ppopulation based; Relative survival; Urinary system

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; COMORBIDITY; DENMARK; FINLAND; FOLLOW UP; HUMAN; ICELAND; KIDNEY CANCER; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SURVIVAL TIME; SWEDEN; TREND STUDY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DENMARK; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; ICELAND; INCIDENCE; KIDNEY NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; NEOPLASM STAGING; NORWAY; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN; URINARY BLADDER NEOPLASMS;

EID: 77952860532     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903575299     Document Type: Article

References (22)

1. Engholm G, Ferlay J, Christensen N, Bray F, Klint Å, Ólafsdóttir E, et al. (2008). NORDCAN: Cancer Incidence, Mortality, and Prevalence in the Nordic Countries, Version 3.3. Association of the Nordic Cancer Registries. Danish Cancer Society (http://www.ancr.nu).
2. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44:1345-1389
3. Silverman DT, Devesa SS, Moore LE, Rothman N. Bladder cancer. In: Schottenfeld D, Fraumeni JF, Jr, editors. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006. pp. 1101-1127
4. McLaughlin JK, Lipworth L, Tarone RE, Blot WJ. Renal Cancer. In: Schottenfeld D, Fraumeni JF, Jr, editors. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006. pp. 1087-1100
5. Dreyer L, Winther JF, Pukkala E, Andersen A. Tobacco smoking. In: Olsen JH, Andersen A, Dreyer L, Pukkala E, Tryggvadottir L, Gerhadsson de Verdier M, et al. Avoidable cancers in the Nordic countries. APMIS 2007;105(Suppl 76):9-47.
6. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, et al. Occupation and cancer-follow-up of 15 million people in five Nordic countries. Acta Oncol 2009;48:646-790.
7. Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic cancer registries. APMIS 1995;103(Suppl 49):1-163.
8. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-991
9. Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 and followed up to the end of 2006. Material and methods. Acta Oncol.
10. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307-2316
11. Hancock BW. Survival from kidney cancer in England and Wales up to 2001. Br J Cancer 2008;99(Suppl 1):S96-S97.
12. Lund EM, Clemmensen IH, Storm HH, Engholm G. Survey of the Nordic Cancer Registries. Copenhagen: Danish Cancer Society; 2000. (http://www.ncu.nu/ancr/ pdf/survey.pdf 29-08-2009)
13. Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009;115:68-74.
14. Katz MH, Steinberg GD. Sex and race in bladder cancer: What we have learned and future directions. Cancer 2009; 115:10-12
15. Whelan P. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer 2008;99(Suppl 1):S90-S92.
16. Nilsson S, Ragnhammar P, Glimelius B, Nygren P; SBUgroup. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol 2001;40:371-390
17. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis. Lancet 2003;361: 1927-1934
18. Eriksen KT, Petersen A, Poulsen AH, Deltour I, Raaschou- Nielsen O. Social inequality and incidence of and survival from cancers of the kidney and urinary bladder in a population- based study in Denmark, 1994-2003. Eur J Cancer 2008;44:2030-2042
19. Westlake S, Cooper N, Rachet B, Coleman MP. Survival from cancers of the kidney and ureter in England and Wales up to 2001. Br J Cancer 2008;99(Suppl 1):S93-S95.
20. Shah A, Rachet B, Mitry E, Cooper N, Brown CM, Coleman MP. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer 2008;99(Suppl 1):S86-S89.
21. Dalton SO, Schüz J, Engholm G, Johansen C, Kjaer SK, Steding-Jessen M, et al. Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: Summary of fi ndings. Eur J Cancer 2008; 44:2074-2085
22. SUSY http://susy2.si-folkesundhed.dk/susy.aspx 27 September 2009 .